Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?
Addiction June 6, 2024 Wayne Hall, Keith Humphreys, John Marsden et al. 18 citations
Abstract The turn of the century brought a resurgence of interest in psychedelics as a treatment for addiction and other psychiatric conditions, accompanied by extensive positive media attention and private equity investment. Government regulatory bodies in Australia, Israel, Canada and the United States now permit use of psychedelics for medical purposes. In the United States, citizen action...